DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

DoubleTree by Hilton Hotel Toronto Downtown

2014 年 10 月 02 日 8:00 上午 - 2014 年 10 月 02 日 4:30 下午

108 Chestnut Street, Toronto, ON M5G 1R3, Canada

DIA Canadian Pharmacovigilance & Risk Management

Session Chair(s)

Rita  Cassola, RPH

Rita Cassola, RPH

Executive Director PV

Certus PV Services Inc, Canada

Speaker(s)

Matthew P LeBrun, MS

Draft Guidance Document for Preparing a Post-Market Benefit-Risk Assessment

Matthew P LeBrun, MS

Health Canada, Canada

Scientific Evaluator

Katarina  Susnjar

Inspections

Katarina Susnjar

Health Canada, Canada

Compliance and Enforcement Specialist, Clinical Trial Compliance Program (CTCP)

Rania  Mouchantaf, PHD

Risk Management Plan Draft Guidance

Rania Mouchantaf, PHD

Health Canada, Canada

A/Executive Director, Marketed Pharmaceuticals Bureau, MHPD

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。